![Shlomo Yanai, Teva's president and chief executive, speaks to the media during a news conference in Tel Aviv July 27, 2010. Teva Pharmaceutical Industries, the world's largest generic drugmaker, reported higher quarterly Shlomo Yanai, Teva's president and chief executive, speaks to the media during a news conference in Tel Aviv July 27, 2010. Teva Pharmaceutical Industries, the world's largest generic drugmaker, reported higher quarterly](https://c8.alamy.com/comp/2D1NC3K/shlomo-yanai-tevas-president-and-chief-executive-speaks-to-the-media-during-a-news-conference-in-tel-aviv-july-27-2010-teva-pharmaceutical-industries-the-worlds-largest-generic-drugmaker-reported-higher-quarterly-net-profit-on-tuesday-boosted-by-sales-of-generic-medicines-and-its-own-branded-multiple-sclerosis-treatment-copaxone-reutersnir-elias-israel-tags-business-headshot-2D1NC3K.jpg)
Shlomo Yanai, Teva's president and chief executive, speaks to the media during a news conference in Tel Aviv July 27, 2010. Teva Pharmaceutical Industries, the world's largest generic drugmaker, reported higher quarterly
![Teva to pay NIS 75 million to Israel authorities to settle foreign bribe claims | The Times of Israel Teva to pay NIS 75 million to Israel authorities to settle foreign bribe claims | The Times of Israel](https://static.timesofisrael.com/www/uploads/2016/12/F131011YS23-e1482425367414.jpg)
Teva to pay NIS 75 million to Israel authorities to settle foreign bribe claims | The Times of Israel
![Israeli authorities cut Teva some slack as foreign bribery case resolved amid other big problems | Fierce Pharma Israeli authorities cut Teva some slack as foreign bribery case resolved amid other big problems | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1516027046/teva1_0.jpg/teva1_0.jpg?VersionId=ylwjgnm4EWdHw9MruiLNspd0I8LT0nz2)